Receptor-binding domain-associated serotypes of SARS-CoV-2

Receptor-binding domain-associated serotypes of SARS-CoV-2

Saved in:

Bibliographic Details
Main Authors:	Zezhong Liu, Lu Lu, Shibo Jiang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Emerging Microbes and Infections
Online Access:	https://www.tandfonline.com/doi/10.1080/22221751.2024.2309968
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions
by: Long V. Pham, et al.
Published: (2024-12-01)

Rationally designed multimeric nanovaccines using icosahedral DNA origami for display of SARS-CoV-2 receptor binding domain
by: Qingqing Feng, et al.
Published: (2024-11-01)

Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2
by: Atharv Athavale, et al.
Published: (2024-12-01)

Lopinavir and Ritonavir have High Affinity Toward the SARS-CoV-2 S-protein Receptor-binding Domain Sequenced in Brazil
by: Aline Diogo Marinho, et al.
Published: (2025-01-01)

Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis
by: Daniele Focosi, et al.
Published: (2024-12-01)

Redirecting a Broad-Spectrum Nanobody Against the Receptor-Binding Domain of SARS-CoV-2 to Target Omicron Variants
by: Kwanpet Intasurat, et al.
Published: (2024-11-01)

Receptor binding and structural basis of raccoon dog ACE2 binding to SARS-CoV-2 prototype and its variants.
by: Chunliang Luo, et al.
Published: (2024-12-01)

Dataset of SARS-CoV-2 spike protein receptor binding domain variants in complex with antigen-binding fragments targeting COVID-19 vaccine-referenced variantsModel Archive
by: Ferdinando Spagnolo, et al.
Published: (2025-02-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

A cGAMP‐Containing Hydrogel for Prolonged SARS‐CoV‐2 Receptor‐Binding Domain Subunit Vaccine Exposure Induces a Broad and Potent Humoral Response
by: Volker Böhnert, et al.
Published: (2025-01-01)

Amino acid T25 in the substrate-binding domain of SARS-CoV-2 nsp5 is involved in viral replication in the mouse lung.
by: Yoshiro Sugiura, et al.
Published: (2024-01-01)

Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
by: Byung Uk Lee
Published: (2021-12-01)

Sensitivity of rodents to SARS-CoV-2: Gerbils are susceptible to SARS-CoV-2, but guinea pigs are not
by: Kiyoko Iwatsuki-Horimoto, et al.
Published: (2024-11-01)

Identification and Ranking of Binding Sites from Structural Ensembles: Application to SARS-CoV-2
by: Maria Lazou, et al.
Published: (2024-10-01)

Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
by: Radi Taha Alsafi
Published: (2022-01-01)

SARS-CoV-2-Neutralizing Antibodies
by: Yawen Liu, et al.
Published: (2024-11-01)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
by: Cucunawangsih Cucunawangsih, et al.
Published: (2021-01-01)

Prevalence of SARS-CoV-2 antibodies at the University hospital Heidelberg and correlation with SARS-CoV-2 incidence
by: C. Bundschuh, et al.
Published: (2024-11-01)

Enhanced Humoral and Cellular Immune Responses Elicited by Adenoviral Delivery of SARS-CoV-2 Receptor-Binding Motif Fused to Human Fc
by: Yea-Jin Lee, et al.
Published: (2024-11-01)

MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodies
by: Olubukola M. Abiona, et al.
Published: (2025-02-01)

Characterization and Fluctuations of an Ivermectin Binding Site at the Lipid Raft Interface of the N-Terminal Domain (NTD) of the Spike Protein of SARS-CoV-2 Variants
by: Marine Lefebvre, et al.
Published: (2024-11-01)

Exosomes and SARS-CoV-2 infection
by: Liuying Li, et al.
Published: (2024-11-01)

Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition
by: Sergio Sánchez-García, et al.
Published: (2024-10-01)

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.
by: Felicitas Ruiz, et al.
Published: (2024-10-01)

Implications of SARS-CoV-2 pandemic on pregnancy
by: Nadia Magallanes-Peláez, et al.
Published: (2024-01-01)

Bat reservoirs related to SARS-CoV-2
by: Sebastian Iglesias
Published: (2020-09-01)

Immune Response Against SARS-CoV-2
by: Angela Stufano, et al.
Published: (2024-12-01)

Myocardial Damage in SARS-CoV-2 Infection
by: Elizabeth Sellén Sanchén, et al.
Published: (2020-11-01)

Clinical Traits of SARS-CoV-2 Infection
by: O. Yu. Zolnikova, et al.
Published: (2020-12-01)

SARS-CoV-2 vaccines in patients with SLE
by: Joan T Merrill, et al.
Published: (2021-05-01)

A multicentre observational study on neonates exposed to SARS-CoV-2 in China: the Neo-SARS-CoV-2 Study protocol
by: Xiao Chen, et al.
Published: (2020-07-01)

Evaluation of IgG binding capability to SARS-CoV-2 variants in early COVID-19 convalescent sera using an indirect ELISA
by: Behzad Hussain, et al.
Published: (2025-02-01)

SARS-CoV-2 Neutralizing Antibodies 2.0
by: Youchun Wang
Published: (2024-11-01)

Probing SARS-CoV-2 membrane binding peptide via single-molecule AFM-based force spectroscopy
by: Qingrong Zhang, et al.
Published: (2025-01-01)

A core network in the SARS-CoV-2 nucleocapsid NTD mediates structural integrity and selective RNA-binding
by: Karthikeyan Dhamotharan, et al.
Published: (2024-12-01)

Identification of potential corticosteroid binding sites on the SARS CoV-2 main protease Mpro — in silico docking study
by: Н. В. Хміль, et al.
Published: (2024-08-01)

Konsistensi Respon Imun Humoral (IgG) SARS-CoV-2 Pasca Vaksinasi SARS-CoV-2 pada Tenaga Kesehatan
by: Abror Irsan, et al.
Published: (2022-04-01)

Colliding Challenges Part 2: An Analysis of SARS-CoV-2 Infection in Patients with Extrapulmonary Tuberculosis Versus SARS-CoV-2 Infection Alone
by: Camil Mihuta, et al.
Published: (2024-12-01)

The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base
by: Sini Huuskonen, et al.
Published: (2024-12-01)

Correction: Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 Infection.
by: Fatemeh Sabzian-Molaei, et al.
Published: (2024-01-01)